Wee Joo Chng, Myeloma
Wee Joo Chng/ncis.com.sg

Wee Joo Chng: New Lancet Series on T-Cell and NK-Cell Lymphomas

Wee Joo Chng, Vice President of Biomedical Science Research at the National University of Singapore and Group Director of Research Office at the National University Health System of Singapore, shared a post on LinkedIn:

“Wanted to share a piece of work published in September during Lymphoma month. This is a beautifully written and illustrated review on the molecular characterization of Extranodal Natural Killer / T-cell lymphoma by William Wee Lee Chan in collaboration with Siok Bian Ng, with illustrations done by Diego A. It a part of the a series across the Lancet journals. The other 2 articles are:

Journal: The Lancet Regional Health – Western Pacific
Title: Epidemiology of mature T-cell and NK-cell neoplasms: East and West
Authors: Yok-Lam Kwong, Huilai Zhangb, Xianhuo Wangb, Eric Tse

Read The Full Article The Lancet.

Wee Joo Chng

Journal: The Lancet Hematology
Title: Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomas
Authors: Prof Eric Tse, MBBS, Prof Christiane Querfeld MD, Prof Kenji Ishitsuka MD, Prof Yok-Lam Kwong MD

Read The Full Article The Lancet Hematology.

Wee Joo Chng

Both written by my good friends, Profs Kwong Yok-Lam and Eric Tse from The University of Hong Kong. This project gave use a chance to do a podcast together. There is also an accompanying commentary.”

Journal: The Lancet Hematology

Title: Advancing understanding of mature T-cell and natural killer-cell lymphomas

Authors: Shunan Qi, Qingqing Cai

Read The Full Article The Lancet Hematology.

Wee Joo Chng

More posts featuring Wee Joo Chng on OncoDaily.